Drugs / InfanrixTM
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01153893 Background | Oct 2010 → Feb 2011 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | InfanrixTM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01153893 ↗ |
| Modality | Vaccine | “Infanrix™ vaccine” NCT01153893 ↗ |
| Route | Intramuscular | “Infanrix™ vaccine was administered intramuscularly in the left thigh or deltoid muscle of the arm.” NCT01153893 ↗ |